Share the post "Zenotech Laboratories announced Financial Results Q1 2024"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 20.33 % in the past year, substantial increase in net sales/revenue by 22.53 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -72.35 %, Marginal decrease of -74.93% in other income during this quarter.
- Profit over the Year and quarter: Challenges in sustaining profitability for Zenotech Laboratories Limited. Profit dropped by -10.73 % Year to Year, Zenotech Laboratories Limited’s profitability increased by 95.45 % in this quarter.
- EPS over the Year and quarter: EPS declined by -12.50 % Year to Year. EPS increased by 90.91 % in previous quarter. Positive impact on shareholders.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 8.238 Cr | Rs. 8.09 Cr | Rs. 9.913 Cr | + 22.53 % | + 20.33 % |
Expenses | Rs. 5.59 Cr | Rs. 6.33 Cr | Rs. 6.48 Cr | + 2.37 % | + 15.92 % |
Operating Profit | Rs. 2.65 Cr | Rs. 1.76 Cr | Rs. 3.43 Cr | + 94.89 % | + 29.43 % |
OPM % | 32.17 % | 21.76 % | 34.6 % | + 12.84 % | + 2.43 % |
Other Income | Rs. 1.219 Cr | Rs. 1.344 Cr | Rs. 0.337 Cr | -74.93 % | -72.35 % |
Interest | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
Depreciation | Rs. 1.8 Cr | Rs. 1.73 Cr | Rs. 1.73 Cr | + 0 % | -3.89 % |
Profit before tax | Rs. 2.07 Cr | Rs. 1.37 Cr | Rs. 2.04 Cr | + 48.91 % | -1.45 % |
Tax % | 30.09 % | 51.93 % | 36.95 % | -14.98 % | + 6.86 % |
Net Profit | Rs. 1.45 Cr | Rs. 0.66 Cr | Rs. 1.29 Cr | + 95.45 % | -11.03 % |
EPS in Rs | Rs. 0.24 | Rs. 0.11 | Rs. 0.21 | + 90.91 % | -12.5 % |
Today, we’re looking at Zenotech Laboratories Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 20.33 %. However, it did see a marginal increase of 22.53 % from the previous quarter. Expenses ticked up slightly by 2.37 % quarter-on-quarter, aligning with the annual rise of 15.92 %. Operating profit, while up 29.43 % compared to last year, faced a quarter-on-quarter increase of 94.89 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 2.43 %, but an expansion of 12.84 % sequentially. Other income fell by -74.93 % compared to the last quarter, despite an annual decline of -72.35 %. Depreciation costs climbed by 0 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -3.89 %. Profit before tax declined annually by -1.45 % but saw an increase from the preceding quarter by 48.91 %.
Tax expenses as a percentage of profits increased slightly by 6.86 % compared to last year, with a more notable quarter-on-quarter decrease of -14.98 %. Net profit fell by -11.03 % year-on-year but experienced a 95.45 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -12.5 % but a quarterly rise of 90.91 %. In summary, Zenotech Laboratories Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 8.238 Cr | Rs. 8.09 Cr | Rs. 9.913 Cr | + 22.53 % | + 20.33 % |
Expenses | Rs. 5.59 Cr | Rs. 6.33 Cr | Rs. 6.48 Cr | + 2.37 % | + 15.92 % |
Operating Profit | Rs. 2.65 Cr | Rs. 1.76 Cr | Rs. 3.43 Cr | + 94.89 % | + 29.43 % |
Net Profit | Rs. 1.45 Cr | Rs. 0.66 Cr | Rs. 1.29 Cr | + 95.45 % | -11.03 % |
EPS in Rs | Rs. 0.24 | Rs. 0.11 | Rs. 0.21 | + 90.91 % | -12.5 % |
In reviewing Zenotech Laboratories Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 20.33 % year-on-year growth, however, there was a minor increase of 22.53 % from the previous quarter. Expenses rose by 15.92 % compared to the previous year, with a 2.37 % increase quarter-on-quarter. Operating Profit surged by 29.43 % annually, and saw a 94.89 % increase from the last quarter.
Net Profit showed yearly decrease of -11.03 %, and experienced a 95.45 % increase from the previous quarter. Earnings Per Share (EPS) fell by -12.5 % annually, however rose by 90.91 % compared to the last quarter. In essence, while Zenotech Laboratories Limited faces strong annual decline indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.